Clinical ResearchHeart FailureRandomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure: The COMPASS-HF Study
Abbreviations and Acronyms
Cited by (0)
This study was supported by Medtronic Inc., Minneapolis, Minnesota.
- 1
Dr. Bourge received a research grant from, honoraria from, and was a consultant/advisory board member for Medtronic Inc.
- 2
Dr. Abraham received a research grant from, honoraria from, and was a consultant/advisory board member for Medtronic Inc.
- 3
Dr. Adamson received research grants from Sigma-Tau, Medtronic Inc., and Cardiomems; honoraria from Medtronic Inc. and Sigma-Tau; and was a consultant/advisory board member for Medtronic Inc., Cardiomems, GlaxoSmithKline, and Sigma-Tau.
- 4
Dr. Aaron received a research grant from Medtronic Inc., was a Speakers’ Bureau member for GlaxoSmithKline, received honoraria from Medtronic Inc., and was a consultant/advisory board member for Medtronic Inc.
- 5
Dr. Aranda received honoraria from and was a consultant/advisory board member for Medtronic Inc.
- 6
Dr. Zile received a research grant from and was a consultant/advisory board member for Medtronic Inc.
- 7
Dr. Smith was a consultant/advisory board member for Medtronic Inc.
- 8
Dr. Smart was a Speakers’ Bureau member for Scios and BioSite, and received honoraria from Scios, BioSite, and Thoratec.
- 9
Dr. Jessup was a Speakers’ Bureau member for Medtronic Inc., GlaxoSmithKline, and AstraZeneca and was a consultant/advisory board member for GlaxoSmithKline, Ventracor, Medtronic Inc., and ACORN.
- 10
Dr. Sparks has ownership interest in and is employed by Medtronic Inc.
- 11
Dr. Stevenson received a research grant from, honoraria from, and was a consultant/advisory board member for Medtronic Inc.